HUM Stock Recent News
HUM LATEST HEADLINES
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana recognizes 10 inspiring National Senior Games athletes who are redefining what it means to age.
BOSTON--(BUSINESS WIRE)--athenahealth, a leading provider of network-enabled software and services for healthcare practices nationwide, in collaboration with key partners Humana (NYSE: HUM) and Your Health, a South Carolina-based primary care practice, have received a 2025 Points of Light Award from KLAS. This recognition is for the case study, “Closing Care Gaps & Reducing the Administrative Burden Through Improved Data Sharing.” This recognition highlights how integrating timely and relev.
NEWTOWN, Pa. , June 9, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. ("Humana") (NASDAQ: HUM), resulting from allegations of providing potentially misleading business information to the investing public.
NEW YORK , June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEWTOWN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. (“Humana”) (NYSE: HUM), resulting from allegations of providing potentially misleading business information to the investing public.
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry, the Wall Street Journal reported, citing staffers and a document viewed by it.
The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.
NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Despite trade war risks, the US economy remains resilient, fueled by robust AI-driven tech spending and strong consumer demand among the wealthy. Market valuations appear high, but growth-adjusted metrics show the S&P is only moderately (15%) overvalued, with strong earnings growth expected to continue. Due to temporary setbacks from Medicare rating downgrades, Humana faces a rare 58% bear-market drop, offering investors a potential extraordinary return during the next five years.